Evidence map›Paper›PMID 28600454›Full record

ReviewThe Biochemical journal2017

The Slo(w) path to identifying the mitochondrial channels responsible for ischemic protection.

Charles Owen Smith, Keith Nehrke, Paul S Brookes

Open access · bronzeAbstract readReview
In one paragraph

Review in The Biochemical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Cardioprotection in right heart failure.British journal of pharmacology · 2020
    Review
  15. Review
  16. Mitochondrial ion channels as targets for cardioprotection.Journal of cellular and molecular medicine · 2020
    Review
  17. Article
  18. Pharmacological modulation of mitochondrial ion channels.British journal of pharmacology · 2019
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Charles Owen SmithDepartment of Biochemistry, University of Rochester Medical Center, Rochester, NY, U.S.A.
Keith NehrkeDepartment of Medicine, University of Rochester Medical Center, Rochester, NY, U.S.A.
Paul S BrookesDepartment of Anesthesiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, U.S.A. paul_brookes@urmc.rochester.edu.
University of Rochester Medical Center · US

Funding

SIRT1, Nitro-Lipids and CardioprotectionR01HL071158 · NHLBI · UNIVERSITY OF ROCHESTER · PI BROOKES, PAUL S · 2003 to 2025
$7.7M
The Role of the Mitochondrial UPR in Ischemic ProtectionR01HL127891 · NHLBI · UNIVERSITY OF ROCHESTER · PI BROOKES, PAUL S, NEHRKE, KEITH · 2015 to 2018
$2.5M
Mitochondrial K+ Channels and CardioprotectionR01GM087483 · NIGMS · UNIVERSITY OF ROCHESTER · PI BROOKES, PAUL S, NEHRKE, KEITH · 2010 to 2017
$2.3M
NHLBI NIH HHS R01 HL071158NHLBI NIH HHS R01 HL127891NIGMS NIH HHS R01 GM087483
6 · The paper itself

Abstract

Mitochondria play an important role in tissue ischemia and reperfusion (IR) injury, with energetic failure and the opening of the mitochondrial permeability transition pore being the major causes of IR-induced cell death. Thus, mitochondria are an appropriate focus for strategies to protect against IR injury. Two widely studied paradigms of IR protection, particularly in the field of cardiac IR, are ischemic preconditioning (IPC) and volatile anesthetic preconditioning (APC). While the molecular mechanisms recruited by these protective paradigms are not fully elucidated, a commonality is the involvement of mitochondrial K

Indexed as

AllostasisModels, BiologicalAnimalsCardiotonic AgentsHumansIon Channel GatingIschemic Preconditioning, MyocardialKATP ChannelsLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMembrane Transport ModulatorsMitochondria, HeartMyocardial IschemiaMyocardial Reperfusion InjuryPotassium Channel BlockersPotassium ChannelsPotassium Channels, Sodium-ActivatedCardiotonic AgentsKATP ChannelsKCNMA1 protein, humanKCNT2 protein, humanLarge-Conductance Calcium-Activated Potassium Channel alpha SubunitsMembrane Transport ModulatorsPotassium Channel BlockersPotassium ChannelsPotassium Channels, Sodium-ActivatedProtein Isoformsanesthetic preconditioningischemic preconditioningmitochondriapotassium channels

Identifiers

PMID28600454
PMCPMC5568769
OpenAlexW2623819267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.